Precipio, Inc.
$28.15
▲
2.01%
2026-04-21 08:57:01
www.precipiodx.com
NCM: PRPO
Explore Precipio, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$50.21 M
Current Price
$28.15
52W High / Low
$29.8 / $5.19
Stock P/E
—
Book Value
$8.18
Dividend Yield
—
ROCE
-6.84%
ROE
-2.72%
Face Value
—
EPS
$-0.23
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
61
Beta
1.2
Debt / Equity
25.09
Current Ratio
1.61
Quick Ratio
1.36
Forward P/E
69.87
Price / Sales
2.02
Enterprise Value
$49.61 M
EV / EBITDA
214.75
EV / Revenue
2.06
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Prenetics Global Limited | $18.2 | — | $300.05 M | — | -28.75% | -31.79% | $23.63 / $3.84 | $10.89 |
| 2. | Veracyte, Inc. | $33.45 | 39.66 | $2.63 B | — | 5.82% | 5.34% | $50.71 / $22.61 | $16.5 |
| 3. | ICON Public Limited Company | $114.42 | 15.51 | $8.76 B | — | 8.66% | 6.27% | $211 / $66.57 | $122.25 |
| 4. | Myriad Genetics, Inc. | $5.14 | — | $484.84 M | — | -11.84% | -23.51% | $8.59 / $3.76 | $3.94 |
| 5. | Medpace Holdings, Inc. | $513.23 | 33.75 | $14.67 B | — | 84.68% | 70.23% | $628.92 / $250.05 | $16.18 |
| 6. | Danaher Corporation | $189.21 | 37.67 | $133.79 B | 0.82% | 6.12% | 7.05% | $242.8 / $180.03 | $74.32 |
| 7. | NeoGenomics, Inc. | $8.23 | — | $1.06 B | — | -6.93% | -12.43% | $13.74 / $4.72 | $6.49 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 6.7 M | 6.77 M | 5.65 M | 4.93 M | 5.45 M | — |
| Operating Profit | 0.54 M | -0.06 M | -0.82 M | -0.86 M | -0.34 M | — |
| Net Profit | 0.53 M | -0.08 M | 0.07 M | -0.88 M | -0.36 M | — |
| EPS in Rs | 0.29 | -0.04 | 0.04 | -0.5 | -0.2 | -0.42 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 24.05 M | 18.53 M | 15.2 M | 9.41 M |
| Operating Profit | -1.2 M | -4.22 M | -7.62 M | -12.8 M |
| Net Profit | -0.36 M | -4.29 M | -5.85 M | -12.2 M |
| EPS in Rs | -0.2 | -2.41 | -3.28 | -6.84 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 21.32 M | 17 M | 18.1 M | 21.5 M |
| Total Liabilities | 6.76 M | 4.9 M | 3.67 M | 5.14 M |
| Equity | 14.56 M | 12.09 M | 14.43 M | 16.3 M |
| Current Assets | 6.04 M | 3.45 M | 3.68 M | 5.71 M |
| Current Liabilities | 3.75 M | 4.27 M | 3.14 M | 4.36 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 0.69 M | 0.44 M | -3.56 M | -7.72 M |
| Investing CF | -0.33 M | -0.22 M | -0.13 M | -0.28 M |
| Financing CF | 0.9 M | -0.33 M | 1.74 M | -0.23 M |
| Free CF | 0.36 M | 0.22 M | -3.69 M | -8 M |
| Capex | -0.33 M | -0.22 M | -0.13 M | -0.28 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 21.95% | 61.46% | — | — |
| Earnings Growth % | 26.7% | 52.04% | — | — |
| Profit Margin % | -23.15% | -38.51% | -129.65% | — |
| Operating Margin % | -22.75% | -50.14% | -135.96% | — |
| Gross Margin % | 40.79% | 39.6% | 26.67% | — |
| EBITDA Margin % | -14.59% | -28.41% | -113.11% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2023-09-22 | 1:0.05 |